Tran Elaine M, Gregori Ninel Z, Rachitskaya Aleksandra, Nandan Abhishek, Pershing Suzann, Goldberg Jeffrey L
Byers Eye Institute at Stanford, Palo Alto, CA.
Bascom Palmer Eye Institute/Miami VA Health Care System, Miami, FL, USA.
Clin Ophthalmol. 2025 Jan 8;19:101-110. doi: 10.2147/OPTH.S487047. eCollection 2025.
To investigate the influence of systemic and serum measures and hypoglycemic medications on the initial presentation and ongoing development of diabetic retinopathy (DR) and diabetic macular edema (DME).
Using Veterans Affairs electronic health records, we identified patients with a diabetes mellitus diagnosis and at least one eye examination between 1997 and 2010. After adjusting for sociodemographic factors, we used multivariable Cox regression models to evaluate the association of hemoglobin A1c (HbA1c) levels, blood pressure, albuminuria, blood urea nitrogen (BUN), and prescribed medications with the subsequent diagnosis of 1) any diabetic eye disease (defined for this analysis as DR and/or DME, 2) diabetic retinopathy, and 3) diabetic macular edema.
Of 4089 diabetic Veteran patients, 821 (20%) were subsequently diagnosed with diabetic retinopathy and 88 (2%) had macular edema. Patients were more likely to receive a diabetic retinopathy diagnosis if they presented with HbA1c > 8.5 (HR=2.66, 95% CI 1.88-3.77, p<0.01), systolic blood pressure > 140 mmHg (HR=1.45, 95% CI 1.26-1.66, p<0.01), blood urea nitrogen (BUN) > 35 mg/dL (HR=2.17, 95% CI 1.60-2.93, p<0.01), and/or used insulin (HR=2.04, 95% CI 1.74-2.40, p<0.01). Patients were more likely to be diagnosed with diabetic macular edema if they had systolic blood pressure > 140 mmHg (HR=2.00, CI 1.29-3.08, p<0.01) and/or used insulin (HR=2.48, CI 1.53-4.03, p<0.01).
Markers of systemic health may be useful predictors for incident diabetic retinopathy or diabetic macular edema, evaluated collectively in Veteran patients. Higher HbA1c levels, systolic blood pressure, BUN levels, and insulin use (suggestive of more severe and/or long-standing diabetes) appear to be highly associated with the development of diabetic eye disease, and, in particular, diabetic retinopathy.
研究全身指标、血清指标及降糖药物对糖尿病视网膜病变(DR)和糖尿病性黄斑水肿(DME)的初始表现及病情进展的影响。
利用退伍军人事务部的电子健康记录,我们确定了1997年至2010年间被诊断为糖尿病且至少接受过一次眼科检查的患者。在对社会人口学因素进行调整后,我们使用多变量Cox回归模型来评估糖化血红蛋白(HbA1c)水平、血压、蛋白尿、血尿素氮(BUN)以及所开具药物与后续诊断的1)任何糖尿病眼病(本分析定义为DR和/或DME)、2)糖尿病视网膜病变和3)糖尿病性黄斑水肿之间的关联。
在4089例糖尿病退伍军人患者中,821例(20%)随后被诊断为糖尿病视网膜病变,88例(2%)患有黄斑水肿。如果患者的HbA1c>8.5(风险比[HR]=2.66,95%置信区间[CI] 1.88 - 3.77,p<0.01)、收缩压>140 mmHg(HR=1.45,95% CI 1.26 - 1.66,p<0.01)、血尿素氮(BUN)>35 mg/dL(HR=2.17,95% CI 1.60 - 2.93,p<0.01)和/或使用胰岛素(HR=2.04,95% CI 1.74 - 2.40,p<0.01),则更有可能被诊断为糖尿病视网膜病变。如果患者的收缩压>140 mmHg(HR=2.00,CI 1.29 - 3.08,p<0.01)和/或使用胰岛素(HR=2.48,CI 1.53 - 4.03,p<0.01),则更有可能被诊断为糖尿病性黄斑水肿。
在退伍军人患者中综合评估时,全身健康指标可能是糖尿病视网膜病变或糖尿病性黄斑水肿发病的有用预测指标。较高的HbA1c水平、收缩压、BUN水平以及胰岛素的使用(提示更严重和/或病程更长的糖尿病)似乎与糖尿病眼病尤其是糖尿病视网膜病变的发生高度相关。